Pemzek PLUS 8/12.5 mg
Pemzek PLUS 8/12.5 mg is a medicine authorised by Swissmedic under authorisation number 62499. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 January 2012 and the authorisation is valid without a time limit. ATC code C09DA06 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 62499 |
|---|---|
| Name | Pemzek PLUS 8/12.5 mg |
| Full name | Pemzek PLUS 8/12.5 mg, Tabletten |
| Authorisation holder | AstraZeneca AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DA06 |
| First authorisation | 06 January 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pemzek PLUS 8/12.5 mg, Tabletten | B | 06 January 2012 |
| 2 | Pemzek PLUS 16/12.5 mg, Tabletten | B | 06 January 2012 |
| 3 | Pemzek PLUS 32/12.5 mg, Tabletten | B | 06 January 2012 |
| 4 | Pemzek PLUS 32/25 mg, Tabletten | B | 06 January 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 2 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 11 | 30 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 3 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 4 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 12 | 30 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 5 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 6 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 7 | 28 | Tablette(n) | C09DA06 | 02.07.2. | B |
| 8 | 98 | Tablette(n) | C09DA06 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Pemzek PLUS 8/12.5 mg authorised in Switzerland?
Yes. Pemzek PLUS 8/12.5 mg is authorised by Swissmedic under authorisation number 62499, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Pemzek PLUS 8/12.5 mg have?
Pemzek PLUS 8/12.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Pemzek PLUS 8/12.5 mg?
The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.